Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion type Assertion NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_head.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion description "[The clinical relevance of these findings was shown in a group of 85 newly diagnosed patients with CML in which expression of hsa-miR-10a was down-regulated in 71% of the patients, whereas expression of USF2 was up-regulated in 60% of the CML patients, with overexpression of USF2 being significantly associated with decreased expression of hsa-miR-10a (P = 0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_provenance.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion evidence source_evidence_literature NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_provenance.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion SIO_000772 19074828 NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_provenance.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion wasDerivedFrom befree-20140225 NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_provenance.
- NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_assertion wasGeneratedBy ECO_0000203 NP835115.RAd29EO_3D5mIYDN2yDpN_pOEZi_EdKfOtz61ufvFwSIc130_provenance.